Structural equation modeling for analyzing erythrocyte fatty acids in Framingham.

PubWeight™: 0.77‹?›

🔗 View Article (PMC 4052884)

Published in Comput Math Methods Med on April 15, 2014

Authors

James V Pottala1, Gemechis D Djira2, Mark A Espeland3, Jun Ye4, Martin G Larson5, William S Harris6

Author Affiliations

1: Health Diagnostic Laboratory Inc., Richmond, VA 23219, USA ; Department of Internal Medicine, Sanford School of Medicine, University of South Dakota, Sioux Falls, SD 57105, USA.
2: Department of Mathematics and Statistics, South Dakota State University, Brookings, SD 57007, USA.
3: Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA.
4: Department of Statistics, University of Akron, Akron, OH 44325, USA.
5: Department of Biostatistics, Boston University School of Public Health, Boston, MA 02218, USA ; Department of Mathematics and Statistics, Boston University, Boston, MA 02215, USA ; Framingham Heart Study, Framingham, MA 01702, USA.
6: Health Diagnostic Laboratory Inc., Richmond, VA 23219, USA ; Department of Internal Medicine, Sanford School of Medicine, University of South Dakota, Sioux Falls, SD 57105, USA ; OmegaQuant Analytics, Sioux Falls, SD 57107, USA.

Articles cited by this

Comparative fit indexes in structural models. Psychol Bull (1990) 50.24

Prediction of coronary heart disease using risk factor categories. Circulation (1998) 48.81

An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol (1979) 18.84

The Sleep Heart Health Study: design, rationale, and methods. Sleep (1997) 7.55

Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med (2002) 7.32

The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med (Maywood) (2008) 5.50

n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr (2006) 5.43

Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res (2008) 4.88

The Omega-3 Index: a new risk factor for death from coronary heart disease? Prev Med (2004) 3.52

Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation (2009) 3.23

Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men. Circulation (2005) 2.12

A new look at the big five factor structure through exploratory structural equation modeling. Psychol Assess (2010) 2.00

Red blood cell ω-3 fatty acid levels and markers of accelerated brain aging. Neurology (2012) 1.81

Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation. Circulation (2004) 1.79

Association of marine omega-3 fatty acid levels with telomeric aging in patients with coronary heart disease. JAMA (2010) 1.71

Docosahexaenoic acid, fatty acid-interacting proteins, and neuronal function: breastmilk and fish are good for you. Annu Rev Cell Dev Biol (2005) 1.55

Diets could prevent many diseases. Lipids (2003) 1.54

Addition of eicosapentaenoic acid to gamma-linolenic acid-supplemented diets prevents serum arachidonic acid accumulation in humans. J Nutr (2000) 1.26

Recent insights into the relation of Δ5 desaturase and Δ6 desaturase activity to the development of type 2 diabetes. Curr Opin Lipidol (2012) 1.19

Clinical correlates and heritability of erythrocyte eicosapentaenoic and docosahexaenoic acid content in the Framingham Heart Study. Atherosclerosis (2012) 1.17

The omega-6/omega-3 ratio and cardiovascular disease risk: uses and abuses. Curr Atheroscler Rep (2006) 1.14

Changes in erythrocyte membrane trans and marine fatty acids between 1999 and 2006 in older Americans. J Nutr (2012) 1.13

Blood eicosapentaenoic and docosahexaenoic acids predict all-cause mortality in patients with stable coronary heart disease: the Heart and Soul study. Circ Cardiovasc Qual Outcomes (2010) 1.13

Fatty acid composition of plasma phospholipids and risk of prostate cancer. Am J Clin Nutr (2009) 1.11

The development of the Mediterranean-style dietary pattern score and its application to the American diet in the Framingham Offspring Cohort. J Nutr (2009) 1.05

Higher RBC EPA + DHA corresponds with larger total brain and hippocampal volumes: WHIMS-MRI study. Neurology (2014) 0.92

Competition between 24:5n-3 and ALA for Delta 6 desaturase may limit the accumulation of DHA in HepG2 cell membranes. J Lipid Res (2007) 0.92

Effect of industrially produced trans fat on markers of systemic inflammation: evidence from a randomized trial in women. J Lipid Res (2011) 0.89

Statistical methodological issues in handling of fatty acid data: percentage or concentration, imputation and indices. Lipids (2012) 0.87

The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk. Semin Vasc Med (2002) 0.86

Red blood cell fatty acids are associated with depression in a case-control study of adolescents. Prostaglandins Leukot Essent Fatty Acids (2012) 0.85

The serum fatty acids myristic acid and linoleic acid are better predictors of serum cholesterol concentrations when measured as molecular percentages rather than as absolute concentrations. Am J Clin Nutr (2009) 0.84

Omega-3 fatty acids and cognitive function in women. Womens Health (Lond Engl) (2010) 0.83

Measurement error adjustment in essential fatty acid intake from a food frequency questionnaire: alternative approaches and methods. BMC Med Res Methodol (2007) 0.78

Structural equations to model relationships between pulmonary function, fatty acids and oxidation in cystic fibrosis. Scand J Clin Lab Invest (2009) 0.77

Are the Adaptogenic Effects of Omega 3 Fatty Acids Mediated via Inhibition of Proinflammatory Cytokines? Evid Based Complement Alternat Med (2011) 0.77